{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:15:03Z","timestamp":1718198103001},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T00:00:00Z","timestamp":1271980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00115-010-2995-7","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T14:49:34Z","timestamp":1271861374000},"page":"956-962","source":"Crossref","is-referenced-by-count":12,"title":["Verlauf und Behandlung der Myasthenia gravis in der Schwangerschaft"],"prefix":"10.1007","volume":"81","author":[{"given":"J.","family":"Klehmet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dudenhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,23]]},"reference":[{"key":"2995_CR1","unstructured":"Armenti V, Radomski JS, Moritz MJ et al (2003) Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 131\u2013141"},{"key":"2995_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0960-8966(94)E0029-8","volume":"5","author":"Barnes","year":"1995","unstructured":"Barnes PR, Kanabar DJ, Brueton L et al (1995) Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother. Neuromuscul Disord 5:59\u201365","journal-title":"Neuromuscul Disord"},{"key":"2995_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.52.3.447","volume":"52","author":"Batocchi","year":"1999","unstructured":"Batocchi AP, Majolini L, Evoli A et al (1999) Course and treatment of myasthenia gravis during pregnancy. Neurology 52:447\u2013452","journal-title":"Neurology"},{"key":"2995_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.1780400527","volume":"40","author":"Buckley","year":"1997","unstructured":"Buckley LM, Bullaboy CA, Leichtman L et al (1997) Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 40:971\u2013973","journal-title":"Arthritis Rheum"},{"key":"2995_CR5","first-page":"35S","volume":"48","author":"Cohen","year":"1976","unstructured":"Cohen BA, London RS, Goldstein PJ (1976) Myasthenia gravis and preeclampsia. Obstet Gynecol 48:35S\u201337S","journal-title":"Obstet Gynecol"},{"key":"2995_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1471-0528.1985.tb01088.x","volume":"92","author":"Davison","year":"1985","unstructured":"Davison JM, Dellagrammatikas H, Parkin JM (1985) Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 92:233\u2013239","journal-title":"Br J Obstet Gynaecol"},{"key":"2995_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0301-2115(02)00051-9","volume":"104","author":"Djelmis","year":"2002","unstructured":"Djelmis J, Sostarko M, Mayer D et al (2002) Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 104:21\u201325","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2995_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V","volume":"86","author":"Enns","year":"1999","unstructured":"Enns GM, Roeder E, Chan RT et al (1999) Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 86:237\u2013241","journal-title":"Am J Med Genet"},{"key":"2995_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2005.01.002","volume":"121","author":"Ferrero","year":"2005","unstructured":"Ferrero S, Pretta S, Nicoletti A et al (2005) Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 121:129\u2013138","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2995_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(53)90201-3","volume":"265","author":"Fraser","year":"1953","unstructured":"Fraser D, Turner JW (1953) Myasthenia and pregnancy. Lancet 265:417\u2013419","journal-title":"Lancet"},{"key":"2995_CR11","first-page":"533","volume":"167","author":"Gaudier","year":"1988","unstructured":"Gaudier FL, Santiago-Delpin E, Rivera J et al (1988) Pregnancy after renal transplantation. Surg Gynecol Obstet 167:533\u2013543","journal-title":"Surg Gynecol Obstet"},{"key":"2995_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1479-828X.2005.00423.x","volume":"45","author":"Gurjar","year":"2005","unstructured":"Gurjar M, Jagia M (2005) Successful management of pregnancy-aggravated myasthenic crisis after complete remission of the disease. Aust N Z J Obstet Gynaecol 45:331\u2013332","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2995_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/tera.1420250207","volume":"25","author":"Hall","year":"1982","unstructured":"Hall JG, Reed SD (1982) Teratogens associated with congenital contractures in humans and in animals. Teratology 25:173\u2013191","journal-title":"Teratology"},{"key":"2995_CR14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/01.WNL.0000082725.21444.EC","volume":"61","author":"Hoff","year":"2003","unstructured":"Hoff JM, Daltveit AK, Gilhus NE (2003) Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 61:1362\u20131366","journal-title":"Neurology"},{"key":"2995_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","volume":"14","author":"Hoff","year":"2007","unstructured":"Hoff JM, Daltveit AK, Gilhus NE (2007) Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 14:38\u201343","journal-title":"Eur J Neurol"},{"key":"2995_CR16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007890-199708270-00002","volume":"64","author":"Jain","year":"1997","unstructured":"Jain AB, Venkataramanan R, Fung JJ et al (1997) Pregnancy after liver transplantation under tacrolimus. Transplantation 64:559\u2013565","journal-title":"Transplantation"},{"key":"2995_CR17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.TP.0000084823.89528.89","volume":"76","author":"Jain","year":"2003","unstructured":"Jain AB, Reyes J, Marcos A et al (2003) Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center\u2019s experience update at 13 years. Transplantation 76:827\u2013832","journal-title":"Transplantation"},{"key":"2995_CR18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.160.5.610","volume":"160","author":"Janssen","year":"2000","unstructured":"Janssen NM, Genta MS (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 160:610\u2013619","journal-title":"Arch Intern Med"},{"key":"2995_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.transci.2007.11.002","volume":"38","author":"Kaynar","year":"2008","unstructured":"Kaynar L, Altuntas F, Aydogdu I et al (2008) Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Transfus Apher Sci 38:109\u2013115","journal-title":"Transfus Apher Sci"},{"key":"2995_CR20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1592\/phco.25.3.438.61590","volume":"25","author":"Kerr","year":"2005","unstructured":"Kerr JR (2005) Neonatal effects of breast cancer chemotherapy administered during pregnancy. Pharmacotherapy 25:438\u2013441","journal-title":"Pharmacotherapy"},{"key":"2995_CR21","doi-asserted-by":"crossref","unstructured":"Klink DT, Elburg RM van, Schreurs MW et al (2008) Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol. 2008:271363","DOI":"10.1155\/2008\/271363"},{"key":"2995_CR22","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/S0041-1345(97)00458-2","volume":"29","author":"Lamarque","year":"1997","unstructured":"Lamarque V, Leleu MF, Monka C et al (1997) Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc 29:2480","journal-title":"Transplant Proc"},{"key":"2995_CR23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/01.AOG.0000124986.32858.ba","volume":"103","author":"Le","year":"2004","unstructured":"Le Ray C, Coulomb A, Elefant E et al (2004) Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 103:1091\u20131094","journal-title":"Obstet Gynecol"},{"key":"2995_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.33.2.133","volume":"33","author":"Lefvert","year":"1983","unstructured":"Lefvert AK, Osterman PO (1983) Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 33:133\u2013138","journal-title":"Neurology"},{"key":"2995_CR25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00115-002-1344-x","volume":"73","author":"Licht","year":"2002","unstructured":"Licht C, Model P, Kribs A et al (2002) Transiente neonatale Myasthenia gravis. Nervenarzt 73:774\u2013778","journal-title":"Nervenarzt"},{"key":"2995_CR26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2004.04140.x","volume":"99","author":"Moskovitz","year":"2004","unstructured":"Moskovitz DN, BodianC, Chapman ML et al (2004) The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99:656\u2013661","journal-title":"Am J Gastroenterol"},{"key":"2995_CR27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2125.1995.tb04555.x","volume":"40","author":"Notarianni","year":"1995","unstructured":"Notarianni LJ, Belk D, Aird SA et al (1995) An in vitro technique for the rapid determination of drug entry into breast milk. Br J Clin Pharmacol 40:333\u2013337","journal-title":"Br J Clin Pharmacol"},{"key":"2995_CR28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bdra.10147","volume":"70","author":"Paladini","year":"2004","unstructured":"Paladini D, Vassallo M, D\u2019Armiento MR et al (2004) Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A Clin Mol Teratol 70:99\u2013100","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2995_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/088307389200700202","volume":"7","author":"Papazian","year":"1992","unstructured":"Papazian O (1992) Transient neonatal myasthenia gravis. J Child Neurol 7:135\u2013141","journal-title":"J Child Neurol"},{"key":"2995_CR30","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1590\/S0100-879X2001001200007","volume":"34","author":"Peres","year":"2001","unstructured":"Peres RM, Sanseverino MT, Guimaraes JL et al (2001) Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 34:1551\u20131559","journal-title":"Braz J Med Biol Res"},{"key":"2995_CR31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00003081-199103000-00012","volume":"34","author":"Plauche","year":"1991","unstructured":"Plauche WC (1991) Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 34:82\u201399","journal-title":"Clin Obstet Gynecol"},{"key":"2995_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1096-9926(200011)62:5<332::AID-TERA7>3.0.CO;2-E","volume":"62","author":"Polizzi","year":"2000","unstructured":"Polizzi A, Huson SM, Vincent A (2000) Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology 62:332\u2013341","journal-title":"Teratology"},{"key":"2995_CR33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.5694\/j.1326-5377.1971.tb92712.x","volume":"2","author":"Powell","year":"1971","unstructured":"Powell HR, Ekert H (1971) Methotrexate-induced congenital malformations. Med J Aust 2:1076\u20131077","journal-title":"Med J Aust"},{"key":"2995_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4","volume":"58","author":"Rodriguez-Pinilla","year":"1998","unstructured":"Rodriguez-Pinilla E, Martinez-Frias ML (1998) Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 58:2\u20135","journal-title":"Teratology"},{"key":"2995_CR35","doi-asserted-by":"crossref","unstructured":"Ross L (1995) Congenital anomalies in two infants born after gestational gamma-globulin prophylaxis. Acta Paediatr. 84:1436\u20131437","DOI":"10.1111\/j.1651-2227.1995.tb13585.x"},{"key":"2995_CR36","unstructured":"Schaefer C, Spielmann H, Vetter K (2006) Immunmodulatoren und Therapie rheumatischer Erkrankungen In: Schaefer C, Spielmann H, Vetter K (Hrsg) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban und Fischer, M\u00fcnchen & Jena S 313\u2013314"},{"key":"2995_CR37","unstructured":"Schaefer C, Spielmann H, Vetter K (2006) Immunmodulatoren und Therapie rheumatischer Erkrankungen In: Schaefer C, Spielmann H, Vetter K (Hrsg) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban und Fischer, M\u00fcnchen Jena, S 679"},{"key":"2995_CR38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9378(84)80172-6","volume":"148","author":"Schmidt","year":"1984","unstructured":"Schmidt PL, Sims ME, Strassner HT et al (1984) Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 148:178\u2013186","journal-title":"Am J Obstet Gynecol"},{"key":"2995_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00115-008-2663-3","volume":"80","author":"Schroder","year":"2009","unstructured":"Schroder A, Ellrichmann G, Chehab G et al (2009) Einsatz von Rituximab in der Behandlung neuroimmunologischer Erkrankungen. Nervenarzt 80:155\u201360 162","journal-title":"Nervenarzt"},{"key":"2995_CR40","first-page":"321","volume":"23","author":"Scott","year":"1977","unstructured":"Scott JS (1977) Immunological diseases in pregnancy. Prog Allergy 23:321\u2013366","journal-title":"Prog Allergy"},{"key":"2995_CR41","unstructured":"Taylor P (1990) Anticholinesterase agents. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. 8th ed. Pergamon, New York, S 131\u2013149"},{"key":"2995_CR42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdra.10060","volume":"67","author":"Vaux","year":"2003","unstructured":"Vaux KK, Kahole NC, Jones KL (2003) Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway? Birth Defects Res A Clin Mol Teratol 67:403\u2013408","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2995_CR43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","volume":"346","author":"Vincent","year":"1995","unstructured":"Vincent A, Newland C, Brueton L et al (1995) Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 346:24\u201325","journal-title":"Lancet"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2995-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-2995-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2995-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T22:42:15Z","timestamp":1591224135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-2995-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,23]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["2995"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-2995-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,23]]}}}